pih 1
TRANSCRIPT
-
7/26/2019 PIH 1
1/44
-
7/26/2019 PIH 1
2/44
Hypertension in PregnancyHypertension in Pregnancy
ClassificationClassificationChronic hypertension
Gestational hypertension (only during pregnancy)
Preeclampsia Superimposed upon chronichypertension or Renal Disease
Preeclampsia - eclampsia
Transient hypertension (only after pregnancy)
-
7/26/2019 PIH 1
3/44
Chronic HypertensionChronic Hypertension
Defined as hypertension
diagnosed
Before pregnancy
Before the 20th week of gestation
During pregnancy and not resolvedpostpartum
-
7/26/2019 PIH 1
4/44
Gestational HypertensionGestational Hypertension
Gestational Hypertension:
Systolic >140
Diastolic>90
No Proteinurea
25% Develop Preecla!psia
-
7/26/2019 PIH 1
5/44
Gestational HypertensionGestational Hypertension
Diagnosis of gestational hypertension: Detected for first time after midpregnancy o proteinuria
!nly until a more specific diagnosis can "e assignedpostpartum
#f preeclampsia does not de$elop and %P returns to normal "y &' ees postpartum* diagnosis is
transient hypertension+
%P remains high postpartum* diagnosis is chronichypertension+
Proteinurea de$elops Preeclampsiais diagnosed (',incidence)
-
7/26/2019 PIH 1
6/44
Hypertension in PregnancyHypertension in Pregnancy
"o!plicates #10% o$ prenancies
#0% Preecla!psiaecla!psia
&0% "'ronic 'ypertension
(cla!psia 0)05% inci*ence
20% o$ +aternal Deat's"ause o$ 10% o$ Preter! ,irt'
(tioloy un-no.n
-
7/26/2019 PIH 1
7/44
Hypertension in PregnancyHypertension in Pregnancy
/oun $e!ale & $ol* increase* ris-
$ricans 2 $ol* increase* ris-
+ulti$etal prenancies
.ins
riplets
Hypertensionenal Disease
"ollaen 3ascular Disease
-
7/26/2019 PIH 1
8/44
Blood pressure
Measure blood pressurein the sitting position, with the
cuff at the level of the heart. Inferior vena caval
compression by the gravid uterus while the patient is
supine can alter readings substantially, leading to an
underestimation of the blood pressure. Blood pressures
measured in the left lateral position similarly may yieldfalsely low values if the blood pressure is measured in
the higher arm and the cuff is not maintained at heart
level.
llow women to sit !uietlyfor "#$0 minutes beforemeasuring the blood pressure.
-
7/26/2019 PIH 1
9/44
%ecord &orotkoff soundsI 'the first sound(and I) 'the muffling of sound( to denote thesystolic blood pressure '*+B( and D+B,respectively. In about " of women, an
e-aggerated gap e-ists between the fourth'muffling( and fifth 'disappearance( &orotkoffsounds, with the fifth sound approaching ero.In this setting, record both the fourth and fifth
sounds 'eg, $20/0/10 with sound I $20, soundI) 0, sound ) 10(.
-
7/26/2019 PIH 1
10/44
-
7/26/2019 PIH 1
11/44
19 years ol* la*y G1 P0 .as seen at t'e antenatal clinic at &2 .ee-s
estation $or routine c'ec- up) n ea!ination s'e loo-e* enerally
.ell6 ,loo* pressure .as 150790 pulse 807! .it' lo.er li!, oe*e!a
) terus .as appropriate $or *ate .it' a via,le $etus) rine analysis
s'o.e* protein)
; .'at is t'e *ianosis
; .'at investiations to per$or!
; .'at treat!ent to co!!ence
19 years ol* la*y G1 P0 .as seen at t'e antenatal clinic at &2 .ee-s
estation $or routine c'ec- up) n ea!ination s'e loo-e* enerally
.ell6 ,loo* pressure .as 150795 pulse 807! .it' lo.er li!, oe*e!a
) terus .as appropriate $or *ate .it' a via,le $etus) rine analysis
s'o.e* protein)
; .'at is t'e *ianosis
; .'at investiations to per$or!
; .'at treat!ent to co!!ence
-
7/26/2019 PIH 1
12/44
19 years ol* la*y G1 P0 .as a*!itte* to t'e la,our .or* at &2 .ee-s
estation co!plainin o$ 'ea*ac'e) n ea!ination s'e loo-e*
enerally un.ell6 irrita,le6 epiastric pain6 nausea < ,loo* pressure.as 1=07110 pulse 907! .it' lo.er li!, an* a,*o!inal .all oe*e!a
6 re$lees eaerate*) terus .as s!all $or *ate .it' a via,le
$etus) rine analysis s'o.e* protein)
; .'at is t'e *ianosis
; .'at investiations to per$or!
; .'at treat!ent to co!!ence
-
7/26/2019 PIH 1
13/44
?N"?D(N"(: 510% 0$ all prenancies ) 20% recurrence
'is is t'e t'ir* !ost i!portant cause o$ !aternal !ortality.orl*.i*e
D(@?N??N @ H/P(A(NS?N:
D)B)P) > 90 !!H or
S)B)P) > 140 !!H or
ise in D)B)P) o$ at least 15 !!H Cp'ysioloical c'anes or
ise in S)B)P) o$ at least &0 !!H
P?(N(:
+roteinurea is defined as urinary e-cretion 0.3 g protein or greater in a 21#hour
30 mg/dl '4$ or greater on urine dip specimen(
(D(+: 90% prenancy)proressive
a,an*one*
7
-
7/26/2019 PIH 1
14/44
E(nlare* placenta e)FFFF)
EPreeistin 'ypertension6 renalEPreeistin vascular *isease
EP0 >>>> !ultip
E@a!ily 'istory
ENe. 'us,an*
-
7/26/2019 PIH 1
15/44
E,nor!al trop'o,last invasionF
$irst 12 .ee-s6 t'e *eci*ual se!ents o$ t'e spiral arteries
are inva*e*F increase* $lo. to interrvellous spaceF ,y 20
.ee-s trop'o,last inva*es intra!yo!etrial se!ent o$ spiral
arteries>>> re*uce resistance to ,loo* $lo. to placenta)C'i'
volu!e
?n P( trop'o,last invasion is patc'y < spiral arteries retain
t'eir !uscular .allsF) eason
-
7/26/2019 PIH 1
16/44
ENor!al prenancy: !ar-e* perip'eral vaso*ilatationF) 4 $ol* increasein prostacyclin CPG?2 nor!al t'ro!,oane an* increase* nitric oi*e ,y
vascular en*ot'eliu!
EPreecla!psia: no c'ane7re*uction in prostacyclin an* N))
synt'esisFF) 3asospas! an* en*ot'elial cell *ys$unction>>> plateletactivation an* !icro areate $or!ation
?t is a !ulti oran a$$ectin *isease7 syn*ro!e
'e!orr'ae an* necrosis in !any orans66 arteriolar constriction
-i*neys: lo!erioloen*ot'eliosis
acute at'erosis o$ spiral arteries6 platelets !icro
areates
-
7/26/2019 PIH 1
17/44
Pathophysiologic Abnormalities in Preeclampsia
Generalized vasospasm Activation of coagulation system Abnormal hemostasis Altered thromboxane-prostacyclin ratio Endothelial cell injury
Abnormal hemodynamics Reduced uteroplacental blood flow
-
7/26/2019 PIH 1
18/44
PathophysiologyPathophysiology
Heart: Generally unaffected. cardiacdecompensation in the presence of pree/istingheart disease+
0idney: Renal lesions (glomerularendotheliosis). G1R and renal "lood flodecrease. hyperuricemia. proteinuria may appearlate in clinical course. hypocalciuria. alterations
in calcium regulatory hormones. impairedsodium e/cretion. suppression of reninangiotensin system+
-
7/26/2019 PIH 1
19/44
PathophysiologyPathophysiology
Coagulation System: Throm"ocytopenia.lo antithrom"in ###. higher fi"ronectin+
2i$er: H322P syndrome (hemolysis* ele$ated 42Tand 4ST* and lo platelet count)+
CS: 3clampsia is the con$ulsi$e phase ofpreeclampsia+ Symptoms may include headache
and $isual distur"ances* including "lurred $ision*scotomata* and* rarely* cortical "lindness+
-
7/26/2019 PIH 1
20/44
Symptoms of PreeclampsiaSymptoms of Preeclampsia3isual *istur,ances typical o$ preecla!psia are
scintillations an* scoto!ata) 'ese *istur,ances are
presu!e* to ,e *ue to cere,ral vasospas!)
Hea*ac'e is o$ ne. onset an* !ay ,e *escri,e* as
$rontal6 t'ro,,in6 or si!ilar to a !iraine
'ea*ac'e) Ho.ever6 no classic 'ea*ac'e o$
preecla!psia eists)
(piastric pain is *ue to 'epatic s.ellin an*in$la!!ation6 .it' stretc' o$ t'e liver capsule) Pain
!ay ,e o$ su**en onset6 it !ay ,e constant6 an* it
!ay ,e !o*eratetosevere in intensity)
-
7/26/2019 PIH 1
21/44
Symptoms of preeclampsiaSymptoms of preeclampsia
A'ile !il* lo.er etre!ity e*e!a is co!!on innor!al prenancy6 rapi*ly increasin ornon*epen*ent e*e!a !ay ,e a sinal o$*evelopin preecla!psia) Ho.ever6 t'is sinalt'eory re!ains controversial an* recently 'as ,eenre!ove* $ro! !ost criteria $or t'e *ianosis o$
preecla!psia)
api* .ei't ain is a result o$ e*e!a *ue tocapillary lea- as .ell as renal so*iu! an* $lui*retention)
-
7/26/2019 PIH 1
22/44
Physical Findings inPhysical Findings in
PreeclampsiaPreeclampsiaBloo* Pressure
Proteinurea
etinal vasospas! or etinal e*e!a
i't upper ua*rant C; a,*o!inal
ten*erness ste!s $ro! liver s.ellin an*
capsular stretc'
-
7/26/2019 PIH 1
23/44
Physical findings inPhysical findings in
PreeclampsiaPreeclampsia Bris-6 or 'yperactive6 re$lees are co!!on
*urin prenancy6 ,ut clonus is a sin o$neuro!uscular irrita,ility t'at raises concern)
!on prenant .o!en6 &0% 'ave so!elo.er etre!ity e*e!a as part o$ t'eir nor!al
prenancy) Ho.ever6 a su**en c'ane in
*epen*ent e*e!a6 e*e!a in non*epen*ent areassuc' as t'e $ace an* 'an*s6 or rapi* .ei't ainsuests a pat'oloic process an* .arrants$urt'er evaluation
-
7/26/2019 PIH 1
24/44
EA'y screenin
Eccuracy) terine artery *oppler at 24 .ee-s6 notc'in on ,ot'
uterine arteries i*enti$ies 80% .'o .ill *evelop P(666 5% $alse
positive
-
7/26/2019 PIH 1
25/44
Maternal
55 6etal
-
7/26/2019 PIH 1
26/44
-
7/26/2019 PIH 1
27/44
Methods Used to Prevent Hypertensive Disorders of Pregnancy
Proper prenatal care ow-salt diet !iuretics
Antihypertensive drugs "utritional supplementation
#agnesium $%&' mg(d) *inc $+, mg(d) alcium $.',,/+,, mg(d)
0ish oil
Antithrombotic agents ow-dose aspirin $',/.', mg(d) !ipyridamole $++'/%,, mg(d) 1ubcutaneous heparin $.'2,,, 34(d)
-
7/26/2019 PIH 1
28/44
Low doses of aspirin do help prevent
pre-eclampsia, but there is littleinformation about whether they are ofbenefit for treatment of established pre-eclampsia cochrane 22 April 2003
Pre-eclampsia is a condition in pregnancy involving high bloodpressure and protein in the urine5 3t can lead to seriouscomplications and death5 As pre-eclampsia affects blood clotting2antiplatelets $drugs li6e aspirin which can prevent blood clots) areused for pre-eclampsia5 7he review of trials found that low doses
of aspirin lowered the ris6 of pre-eclampsia a little $.'8 loweringin the ris6)2 with a similar lowering in the ris6 of the baby dying$.98) and a very small lowering in the ris6 of the baby beingborn too early $:8)5 !oses less than ;'mg appear to be safe5
-
7/26/2019 PIH 1
29/44
alcium supplements may prevent high blood
pressure and help prevent preterm labour!cochrane 22 April 2003
%eviewers7 conclusions8"alciu! supple!entation appears to ,e ,ene$icial $or .o!en at
'i' ris- o$ estational 'ypertension an* in co!!unities .it' lo.
*ietary calciu! inta-e) pti!u! *osae reuires $urt'er
investiation)
Main results8
(leven stu*ies .ere inclu*e*6 all o$ oo* uality) 'ere .as a !o*est
re*uction in 'i' ,loo* pressure .it' calciu! supple!entation ) 'e e$$ect
.as reatest $or .o!en at 'i' ris- o$ 'ypertensionCrelative ris- 0)456 95%
con$i*ence interval 0)&1 to 0)== an* t'ose .it' lo. ,aseline *ietary calciu!
Crelative ris- 0)496 95% con$i*ence interval 0)&8 to 0)=2)
-
7/26/2019 PIH 1
30/44
9:;;+ *M:
B%?+@I> +;A:=@:
+?;M>=%< >:D:M
A?@: %:=; 6I;?%:A:%:B%; 9:M>%%9:
)I*?; DI*@?%B=A:* C B;I=D=:**
9:+@IA %?+@?%:
:;:A@%>;*@+%@?M A>;;+*:
S3R#!5S C!6P2#C4T#!S: -
H/P((NS?N D?NG P(GNN"/
-
7/26/2019 PIH 1
31/44
A?%: / +%:):=@ +%>%:**I>= #
A;>*: M>=I@>%I=
%:D?A: B;>>D +%:**?%: #@@%:@# $10/0
+%>M>@: 6>:@; M@?%I@;>= +%:==A< '31 # 3E F::&*(
@> A9I:): 6>:@; M@?%I@< @:%MI=@I>=
D:;I):%BG:A@I):* >6 M=:M:=@
H/P((NS?N D?NG P(GNN"/
H/P((NS?N D?NG P(GNN"/
-
7/26/2019 PIH 1
32/44
;>>& 6>% ++:%=A: >6 >MI=>?*
6:@?%:*
DI;%D B.+ 1 @IM:*, M>=I@>%?%I=: >?@+?@ C @:*@ 6>% +%>@:I=?%I
H?;I. / H?=@
;@.DD< F:I9@:):%< 1@9 D?=@, ;.6.@. ';D9(
F::&;
-
7/26/2019 PIH 1
33/44
DI;< # A;I=IA; 6>:@; M>=I@>%I= #
69*, 6?=D; 9t. BD>MI=; I%@9,
;IH?>%, 6>:@; M>):M:=@ A>?=@, A.@.?* # >= DMI**I>= C @9:= 3 F::&;% 6>:@; BI>+9% )>;?M:D>+;;:% ?* 6>% +;A:=@; B;>>D
6;>F ):;>AI@< :):%< 1@9 D 6>% M@?%I@ 5F 4C0. S.6.,. H7P.,0./S85/
0here is no consens$s on the optim$m ac$te treatment&
0he important o(
-
7/26/2019 PIH 1
42/44
0here is still ins$fficient trial evidence to determine whether the (enefits o$tw
any disadvantages& 8f it is to (e $sed the s$ggested indications are: -#BP ?@1!! mmHg
-pregnancy A@=2 wee9s
fetal and maternal state otherwise good&
"ethyldopa remains the dr$g of first choice&
7he combined a- and $B- bloc6ing agent labetalol is commonly used5
7he potent vasodilator and calcium channel bloc6er nifedipine is a usesecond-line treatment5 3ts major drawbac6 is severe headache5
Angiotensin-converting enzyme (AC! inhibitors have deleterious fetal effeand their use is not recommended5 3f a woman with chronichypertension becomes pregnant on an AE inhibitor2 change to anotanti-hypertensioe agent is advised5
>5/.,-0.,3 C5/0,5> 5F S.6.,. H7P.,0./S85/
-
7/26/2019 PIH 1
43/44
77iming of delivery? 7he most common grounds for delivery are>progressive fetal compromise $i5e5 when the baby is safer
delivered)uunacceptable ris6 to maternal health2 e5g5 uncontrollable BP2impending renal failure or heart failure2
-
7/26/2019 PIH 1
44/44
@he mode of delivery 'caesarean section versus vaginal( depends
on8
t'e seriousness o$ t'e situation
t'e estational ae
t'e *eree o$ $etal7!aternal co!pro!ise)
E (pi*ural analesia is t'e !et'o* o$ c'oice $or la,our Cas lonas a
coaulation *e$ect 'as ,een eclu*e*)
E ppropriate $acilities $or t'e care o$ t'e ne.,orn availa,le